FBP1 and colorectal cancer: In terms of tumor metabolism, CBX3 has been verified to be involved in the anaerobic glycolysis of colorectal cancer cells [30]; Chen et al. [31] showed that CBX3 can promote the proliferation of pancreatic cancer by inhibiting the negative regulator of aerobic glycolysis FBP1.